MedTrace Logo

Exploratory Study of the Usability, Feasibility, and Perception for Tele-cardiac Rehabilitation (Tele-CR) Program

NCT06816693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-03-20

No results posted yet for this study

Summary

The goal of this mixed prospective observational and qualitative studies is to evaluate the usability of a newly developed application (App) and the feasibility and perception of a 12 weeks tele-cardiac rehabilitation (tele-CR) program. The main question it aims to answer is: Does tele-CR program intervention a acceptance feasibility in coronary heart disease patients? The findings will guide subsequent intervention design studies.

Conditions

Interventions

BEHAVIORAL

tele-CR program

Following the completion of basic characteristics assessment prior to discharge, a 12 weeks tele-CR program was implemented for all participants. The tele-CR program is divided into three parts: motivational interview, App delivery, and self-management and tracking. The motivational interviewing during hospitalization, which involved evaluating individual risk factors, setting behavioral goals, and providing training on the installation and operation of the tele-CR App (approximately 30-60 minutes per session). After discharge, the researchers monitored App usage and conducted four follow-up sessions via LINE or telephone at 1, 4, 8, and 12 weeks post-discharge. These follow-ups, lasting approximately 5-15 minutes each, aimed to assess patients' living conditions, resolve any issues promptly, and provide encouragement or praise based on their engagement with the App.

Sponsors & Collaborators

  • Chang Gung University

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • National Science and Technology Council

    collaborator FED

  • Chang Gung University of Science and Technology

    lead OTHER

Principal Investigators

  • Ching-Ching Tsai, Associated Professor · Chang Gung University of Science and Technology

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06816693 on ClinicalTrials.gov